Literature DB >> 10966251

Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit.

J P Sculier1, M Paesmans, E Markiewicz, T Berghmans.   

Abstract

OBJECTIVE: To validate and compare two severity scoring systems, the Acute Physiology and Chronic Health Evaluation (APACHE) II and Simplified Acute Physiology Score (SAPS) II and to determine their prognostic value for mortality during the hospital stay and after discharge in a specific group of cancer patients admitted to intensive care unit (ICU) for an acute medical complication.
DESIGN: Prospective cohort study.
SETTING: The medical ICU of a European cancer hospital.
SUBJECTS: A total of 261 consecutive cancer patients admitted to ICU for an acute medical complication. MEASUREMENTS: Variables included into the APACHE II and SAPS II scores, as well as characteristics of the cancer, were collected during the first 24 hrs of the ICU stay. Hospital and in-ICU mortalities, overall survival, and survival after day 30 were measured.
RESULTS: Observed hospital and ICU mortalities were 33% and 23%. Median survival time was 94 days and 1-yr survival rate was 23%. The mean predicted risk of death was 26.5% with APACHE II and 26.1% with SAPS II. Correlation between both systems was excellent. Calibration for mortality prediction ability of both scoring systems was similar. Discrimination between survivors and nonsurvivors was superior with SAPS II according to the area under the receiver operating characteristic curve but was better with APACHE II for survivors using thresholds minimizing the overall misclassification rates. Multivariate prognostic analysis showed that the scoring systems were the only significant factors for hospital and in-ICU mortalities, whereas characteristics related to the cancer (extent, phase) were the factors predicting survival after discharge.
CONCLUSION: The prognosis of cancer patients admitted to ICU for a medical problem is first determined by the acute physiologic changes induced by the complication, as evaluated by the severity scores. There is no major difference between the two assessed scoring systems. They are, however, not accurate enough to be used in the routine management of these patients. After recovery from complications, characteristics related to the neoplastic disease, however, retrieve their independent influence on the further survival.

Entities:  

Mesh:

Year:  2000        PMID: 10966251     DOI: 10.1097/00003246-200008000-00018

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  31 in total

1.  Validation of the SAPS 3 admission prognostic model in patients with cancer in need of intensive care.

Authors:  Márcio Soares; Jorge I F Salluh
Journal:  Intensive Care Med       Date:  2006-09-15       Impact factor: 17.440

2.  The intensive care support of patients with malignancy: do everything that can be done.

Authors:  Elie Azoulay; Bekele Afessa
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

Review 3.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

4.  Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU.

Authors:  B Lamia; M-F Hellot; C Girault; F Tamion; F Dachraoui; P Lenain; G Bonmarchand
Journal:  Intensive Care Med       Date:  2006-08-01       Impact factor: 17.440

5.  Leucopenia is an independent predictor in cancer patients requiring invasive mechanical ventilation: a prognostic factor analysis in a series of 168 patients.

Authors:  F Vallot; M Paesmans; T Berghmans; J P Sculier
Journal:  Support Care Cancer       Date:  2003-01-22       Impact factor: 3.603

6.  Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit.

Authors:  Stephen M Pastores; Debra A Goldman; David J Shaz; Natalie Kostelecky; Ryan J Daley; Tim J Peterson; Kay See Tan; Neil A Halpern
Journal:  Cancer       Date:  2018-05-04       Impact factor: 6.860

7.  Comparison of three severity scores for critically ill cancer patients.

Authors:  Peter Schellongowski; Michael Benesch; Thomas Lang; Friederike Traunmüller; Christian Zauner; Klaus Laczika; Gottfried J Locker; Michael Frass; Thomas Staudinger
Journal:  Intensive Care Med       Date:  2003-11-04       Impact factor: 17.440

8.  Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience.

Authors:  Christelle Ferrà; Pilar Marcos; Maite Misis; Mireia Morgades; María-Luisa Bordejé; Albert Oriol; Natalia Lloveras; Juan-Manuel Sancho; Blanca Xicoy; Montserrat Batlle; Jordi Klamburg; Evarist Feliu; Josep-Maria Ribera
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

9.  Six-month prognosis of patients with lung cancer admitted to the intensive care unit.

Authors:  Sébastien Roques; Antoine Parrot; Armelle Lavole; Pierre-Yves Ancel; Valérie Gounant; Michel Djibre; Muriel Fartoukh
Journal:  Intensive Care Med       Date:  2009-09-19       Impact factor: 17.440

10.  APACHE III outcome prediction in patients admitted to the intensive care unit after liver transplantation: a retrospective cohort study.

Authors:  Mark T Keegan; Bhargavi Gali; James Y Findlay; Julie K Heimbach; David J Plevak; Bekele Afessa
Journal:  BMC Surg       Date:  2009-07-29       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.